Member Info for Toukankahmoon

Buen

Since when was honesty important in posts on this BB?

But seriously - I apologised and corrected my post later on though as I recall you didn’t accept my apology then.

Things would be different if you hadn’t marked me down as a devious deramper. I could praise Avacta to the heavens and you would still twist the words into a deramp.

But my point here is pointing out what CC said about why the decided addressing TNBC was a very good way forward = because mid FAP cleaves AVA6000 and a great opportunity exists via an oncologist she knows in a breast cancer clinic in the US. NOT the ChatGPT garbled analysis that Icecool is pedalling to boost his ego.

Just saying

I had already posted on 8 Nov:;

“RE: Video8 Nov 2024 23:42

Buen

Video worth waiting for. Pipeline potential is mind blowing as is AVA6000 use in breast cancer in the interim. I now understand why arm2 results not of great significance (reduced to 3 cohorts by the end). Also understand issues so far in that doxorubicin not very effective against STS (1 min 20secs in). So P2 timeline has increased (breast cancer trials take longer and are more costly) but the rewards will be huge. However I think that you will have plenty more opportunities to buy shares at the current SP or thereabouts.

In conclusion this video is most thorough yet in explaining what is happening and where we are going A bright future indeed.”

Trust that this clears things up

On 14 Nov I posted::

“We already know the significant stuff from P1.

1. Safety/tolerability not compromised by more frequent dosing.

2. Mechanism works well with mid FAP tumours opening up more tumour types for potential treatments including of course breast cancer.

What else are you expecting?”

AVCT

No BP direct involvement until decent P1b results start appearing

Some funding and most if not all US patients will be from the breast cancer clinic.

Buen

I believe some funding will come from the breast cancer clinic I mentioned who will also have easy access to potential patients. They may have a BP partner in the background

Icecool

No not the JP conference again

icecool

it’s got nothing to do with secretly including tnbc in some extra trial. it’s because of ava6000 showing some action on mid fap tumours opening up possibility of use on tnbc. and cc’s mate telling her “this is brilliant because more of my tnbc patients die because of the collateral effect of doxorubicin in the chemotherapy ****tail they receive than the original tumours”

but you continually ignore this because it doesn’t fit your narrative o you being super sleuth.

in any case, relax for next 6 months.

Almost everyone on here accepts that the platform works.

Most accept that limited cases of efficacy so far are encouraging. Not my words.

But we are still in P1.

Icecool

All excellent stuff. Some of it cone interpreted as new.

But it does nothing to get us to the end game.

Apologies

I meant clinical trials in terms of efficacy. We only have P1a results for safety and tolerability so far.

HarChris

As I said, the interview potentially provides more visibility but it only validates the mechanism not any actual clinical results. It’s great but not worth yesterday’s hysteria. It doesn’t move us forward any.

Could you explain how it gets us a NASDAQ listing? Do we even want one right now with the inherent dilution it is likely to bring?

Excellent interview. But we knew all that. Great to get the message out to a wider audience and especially influential oncologists.

None of what has been said shortens the timelines. In fact he talks about the purpose of Phase 3.

You guys continually tell us that “it works” - and I agree - so why the hysteria????

Relax for 6 months and wait for P1b initial results to start coming through.

I would cite the communication in which CC said it but you would only find another point to argue. And in any case I can’t be bothered.

Relax for the next 6 months

A1invest

Great interview thanks for posting

icecool

you are right. i only care about decent p1b results being published which will be the trigger for a lot of good things.

i use chatgpt a great deal and you know as well as i do that you can manipulate the answers by the way you phrase the question. i think in law it is termed “leading the witness”.

the reason tnbc is being included now has been clearly documented by cc.

1. results nearly a year ago showed ava6000 being efficacious on mid fap tumours(=tnbc)

2. one of cc’s mates in usa told her that a lot of his tnbc patients were dying from the collateral effects of doxorubicin in the chemotherapy ****tail they were being given rather than the tumours (which had been destroyed). this was a lightbulb moment. it means ava6000 could save lives in a massive number of tnbc patients.

so please relax and wait for p1b results.

Icecool

Relax. Enjoy your weekend.

Then take it easy for 6 months or so until some clear results start appearing from P1b.

Icecool

This isn’t aimed at you in particular.

I’m just fed up that each time a communication comes out it has to be analysed out of sight for any nuance that suggests something more positive than the bare bones of what it actually says. God how desperate do people have to be.

Unless what you think is going on is announced in an updated RNS , I just don’t care. I can wait.

Bella

You don’t say one way or another, so I hope your hubby is ok❤️

They probably thought that TNBC is so unimportant it wasn’t worth mentioning. Yeah that’ll be it. But don’t let that stop a good ramp.

Regardless what does it matter. It was certainly taken into account in the latest timelines. So it doesn’t matter either way other than to keep Icecool amused.

Icecool

It is always good to read your positive analysis and at least it makes me think unlike the offensive posts of Watching et al